SPARTALIZUMAB

UNII: QOG25L6Z8Z
Preferred Substance Name: SPARTALIZUMAB

1935694-88-4
ANTI-PD1 MONOCLONAL ANTIBODY PDR001
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1)(HUMAN-MUS MUSCULUS MONOCLONAL CLONE NVS240118 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CLONE NVS240118 .KAPPA.-CHAIN, DIMER
NVP-LZV184
PDR001
PDR-001
SPARTALIZUMAB [INN]
SPARTALIZUMAB [JAN]
SPARTALIZUMAB [USAN]
SPARTALIZUMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

SPARTALIZUMAB

Synonyms and Mappings

Resources

Note